<DOC>
	<DOCNO>NCT00095745</DOCNO>
	<brief_summary>This trial 52-week safety study evaluate safety adjunctive aripiprazole outpatient major depressive disorder experience incomplete response ongoing antidepressant trial .</brief_summary>
	<brief_title>A Long-Term Study Aripiprazole Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Men woman , 18 year old Experiencing Major Depressive Disorder duration minimally 8 week . Treatment history inadequate response least one four antidepressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>